Related Experiment Video

Updated: Jun 17, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Specific regulation of point-mutated K-ras-immortalized cell proliferation by a photodynamic antisense strategy

Maiko Higuchi1, Asako Yamayoshi, Kiyoko Kato

  • 1Department of Biomolecular Engineering, Kyoto Institute of Technology, Matsugasaki, Kyoto 606-8585, Japan.

Oligonucleotides
|December 30, 2009
PubMed

Insights

Photoreactive antisense oligonucleotides selectively inhibit mutant K-ras gene expression. This targeted approach shows promise for developing new anticancer drugs by regulating disease-causing point mutations.

Area of Science:

  • Molecular Biology
  • Medicinal Chemistry
  • Oncology

Background:

  • Point mutations in genes are a significant cause of various cancers.
  • Selective gene expression regulation is crucial for developing novel anticancer therapies.
  • Antisense oligonucleotides offer a potential strategy for targeting specific gene sequences.

Purpose of the Study:

  • To investigate the gene regulatory effects of photoreactive antisense oligonucleotides.
  • To evaluate the efficacy of 2'-O-psoralenylmethoxyethyl adenosine (2'-Ps-eom) in targeting mutant K-ras.
  • To assess the therapeutic potential of 2'-Ps-eom as an anticancer drug.

Main Methods:

  • Design and synthesis of photoreactive antisense oligonucleotides containing 2'-Ps-eom.
  • Demonstration of sequence-specific photo-cross-linking between 2'-Ps-eom and target mutant K-ras mRNA.
  • Assessment of UVA irradiation-dependent gene regulation and cellular proliferation inhibition.

Main Results:

  • 2'-Ps-eom exhibited strictly sequence-specific photoreactivity with target mRNAs.
  • Photo-cross-linking efficiency was dependent on UVA irradiation.
  • 2'-Ps-eom selectively inhibited the proliferation of K-ras-immortalized cells (K12V) but not wild-type cells (Vco).

Conclusions:

  • 2'-Ps-eom demonstrates potent and sequence-specific inhibition of mutant K-ras gene expression.
  • The findings suggest 2'-Ps-eom is a promising nucleic acid drug candidate for targeting point mutation-driven cancers.
  • This approach holds significant therapeutic potential for treating cancers caused by specific gene mutations.

More Related Videos

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...